Ask Mallard
Study design

Cost-effectiveness and cost-utility analysis

4 min read

Compare the extra cost of a strategy with the extra health it produces, using a shared perspective and time horizon.

NHMRC EVIDENCE LEVEL · 2009Outside the NHMRC hierarchy
Why this level?not one of the five research areas this hierarchy covers. NHMRC 2009 source

Economic value is not one of the five research areas this hierarchy covers. The evidence label is not a judgment on the quality of the evaluation.

Fit

When to use it, and when not to

Use it when

  • You need to judge health gained for the resources spent.
  • You can estimate costs and health outcomes for relevant alternatives.

Not when

  • You need next year's cash requirement. Use a budget impact analysis.
  • You only need a treatment effect. Use a randomized trial when feasible. Read: Randomized controlled trial

Before you start

What you need

Decide these first
  1. The decision, population and comparatorsInclude the care that would otherwise be used.
  2. Whose costs countA health service and society can count different costs. State currency and price year.
  3. The time horizon and discount rulesUse a horizon that captures important differences. Discount future costs and health as local guidance requires.
  4. The health outcomeDefine natural health units or quality-adjusted life-years. One such year combines time alive with a health-state value.
  5. Inputs and their uncertaintyState evidence sources, model assumptions, missingness assumptions and plausible alternative scenarios.
It rests on these
  1. Health effects are credible for the target population.How to check: Appraise their study design and whether results transfer to the decision setting.
  2. Costs and health cover the same comparison and horizon.How to check: Check the model against the decision and avoid mixing perspectives.
  3. The decision reflects uncertainty in costs and effects.How to check: Vary key assumptions and jointly sample uncertain inputs with their dependencies.

Plain language

How it works

Estimate costs and health under each strategy. Subtract the comparator totals to get incremental cost and health, meaning the extra amounts. Divide extra cost by extra health when that ratio has a useful interpretation.

What to preserve

Cost-utility analysis is this framework with health in quality-adjusted life-years. It does not value health in money. Assess uncertainty and whether another strategy costs less and works better. Report what changes when assumptions or the decision threshold change. Use CHEERS 2022 to report the decision, inputs, uncertainty and economic results.

Cost-effectiveness and cost-utility analysis in outline
Compare cost and health differences for the same population, perspective and horizon. A value judgment also needs a threshold and uncertainty.Cost-effectiveness and cost-utility analysisCosts and health: new strategyCosts and health: comparatorEstimate extra cost and healthJudge value with uncertaintyCompare cost and health differences for the same population, perspective and horizon. A value judgmentalso needs a threshold and uncertainty.
Conceptual diagram. It shows the structure of the idea, not data from any study.

Worked example

A worked example

Invented for illustration
Setting
A service compares two care strategies over the same horizon.
Question
Is the added health worth the extra cost?
Approach
Use a health-service perspective. Both cost and health figures are invented totals per person.
Result
Costs rise from $1000 to $1200, an extra $200. Health rises from 4.0 to 4.1 quality-adjusted life-years. The ratio is $2000 per added quality-adjusted life-year.
What it means
Compare this ratio with the decision maker's value threshold and uncertainty. The ratio alone does not show affordability.

In practice

Recent studies PubMed search · not vetted

Searching PubMed…

Watch out

Common mistakes

The one to remember

Value depends on the comparator, perspective, time horizon and health measure. A cost-effective option may still be unaffordable, and a ratio alone hides uncertainty.

  • Comparing average cost per outcome within each strategy.Instead: Compare the differences between strategies. Check for options that cost more and deliver less health.
  • Reporting only a ratio.Instead: Show differences in cost and health, uncertainty, and the decision threshold. A near-zero health difference can make the ratio unstable.

Inside Mallard

How Mallard uses this

Plans do not link to this design yet. Mallard has no dedicated sizing form for cost-effectiveness and cost-utility analysis.

No Mallard code example points to this page.
Atlas node design.cost_effectiveness_utility, the id a plan cue records.

Related Learn pages

Related designs and methods

Evidence

Sources & further reading

  1. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS (opens in a new tab) · Diabetes Care · doi 10.2337/dc11-1468
  2. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States (opens in a new tab) · Ann Intern Med · doi 10.7326/M14-1336
  3. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (opens in a new tab) · Value Health · doi 10.1016/j.jval.2021.11.1351
Prepared with AI assistance; source titles, authors, years and DOIs checked against PubMed on 2026-11-06. No independent professional approval is claimed. The DPP/DPPOS study supports collecting costs and quality of life alongside a trial. Chhatwal and colleagues illustrate a model-based cost-utility decision and distinguish value from spending.
Last source review: 2026-11-06
AI-generated educational content
Mallard uses reputable methodological and reporting sources, but this material may contain errors or omit important context. Verify important methodological decisions with the cited sources and, when appropriate, a qualified research methodologist or statistician.